Altamira Therapeutics Ltd.: xbrl:AccrualsClassifiedAsCurrent
| Value | {"unit": "CHF", "value": 1593171} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/e22238fa-9b9c-43ea-8052-89a951778932
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-046965Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/e22238fa-9b9c-43ea-8052-89a951778932
History
- no predecessors — first report